PAPLN
protein-codingpapilin, proteoglycan like sulfated glycoprotein, the group of ADAMTS like|I-set domain containing
Gene summary
Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in extracellular matrix organization and nervous system development. Predicted to be located in basement membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~37.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PAPLN variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001365906.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 3 | 5 | |||
| missense | 233 | 25 | 1 | 259 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 7 | 1 | 8 | |||
| Total | 0 | 0 | 243 | 29 | 1 | 273 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001352835.1 | 26 | MANE Select | |
| Ensembl | ENSP00000495882.2 | 26 | MANE Select | |
| RefSeq | NP_001352836.1 | 26 | Standard | |
| RefSeq | NP_775733.3 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- proteolysis
- negative regulation of endopeptidase activity
Molecular Function
- serine-type endopeptidase inhibitor activity
- peptidase activity
Cellular Component
- extracellular region
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000340738
- Coding exons
- 25
- Length
- 37144
- Individuals with no LoFs
- 124292
- Homozygous LoFs
- 6
- Heterozygous LoFs
- 1450
- Defined
- 125748
- p
- 0.00581
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.426 | 719 | 752 | 0.956 | 0.0000473 | 7948 |
| Missense (PolyPhen) | 233 | 266.26 | 0.87507 | 2952 | ||
| Synonymous | -0.370 | 330 | 322 | 1.03 | 0.0000217 | 2533 |
| Loss of Function | 0.599 | 60 | 65.2 | 0.920 | 0.00000341 | 691 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0025 | 0.0025 | notable |
| Latino/Admixed American | 0.0027 | 0.0025 | notable |
| Ashkenazi Jewish | 0.016 | 0.015 | notable |
| East Asian | 0.0046 | 0.0045 | notable |
| Finnish | 0.0075 | 0.0072 | notable |
| European (Non-Finnish) | 0.0072 | 0.0068 | notable |
| South Asian | 0.0049 | 0.0048 | notable |
| Other | 0.0040 | 0.0038 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- LoFtool
- 0.970
- RVIS EVS
- 1.27
- RVIS percentile EVS
- 93.61
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.183
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |